Back
Medipal Holdings Vs. Nxera Pharma Industry Stock Comparison
Sell
42
MAHLY
Medipal Holdings
Last Price:
15.60
Seasonality Move:
-0.22%
Sell
25
SOLTF
Nxera Pharma
Last Price:
6.95
Seasonality Move:
17.26%
Sell
42
Medipal Holdings (MAHLY)
is a Sell
Is Medipal Holdings a Buy, Sell or Hold?
- The current Medipal Holdings [MAHLY] share price is $14.95. The Score for MAHLY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- MAHLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $7.41. The Score for SOLTF is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MAHLY Stock Price Chart
What is Medipal Holdings's stock price today?
-
The Medipal Holdings share price today is $14.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MAHLY is experiencing slight buying pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $7.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
MAHLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.43 | Sell |
Relative Strength Index (14 RSI): | 17.29 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.41 - 16.23) | Sell |
Bollinger Bands (100): | (14.9 - 17.98) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 28.53 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.54 - 8.1) | Sell |
Bollinger Bands (100): | (7.71 - 9.81) | Sell |
MAHLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.51 | Sell |
20-day SMA: | 15.74 | Sell |
50-day SMA: | 16.89 | Sell |
200-day SMA: | 15.79 | Sell |
8-day EMA: | 15.37 | Sell |
20-day EMA: | 15.78 | Sell |
50-day EMA: | 16.33 | Sell |
200-day EMA: | 16.12 | Sell |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.49 | Sell |
20-day SMA: | 7.83 | Sell |
50-day SMA: | 7.99 | Sell |
200-day SMA: | 9.32 | Sell |
8-day EMA: | 7.52 | Sell |
20-day EMA: | 7.7 | Sell |
50-day EMA: | 8.02 | Sell |
200-day EMA: | 9.2 | Sell |
Medipal Holdings Earnings Growth & MAHLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Medipal Holdings Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |